These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37726767)

  • 1. Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer.
    Wang X; Yu J; Wen H; Yan J; Peng K; Zhou H
    BMC Urol; 2023 Sep; 23(1):148. PubMed ID: 37726767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer.
    Barquilha CN; Santos NJ; Monção CCD; Barbosa IC; Lima FO; Justulin LA; Pértega-Gomes N; Felisbino SL
    Oxid Med Cell Longev; 2020; 2020():2148562. PubMed ID: 32411320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma.
    Xu Z; Chen S; Zhang Y; Liu R; Chen M
    Front Immunol; 2022; 13():869759. PubMed ID: 35603206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
    Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
    Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
    Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
    Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.
    Piao S; Zheng L; Zheng H; Zhou M; Feng Q; Zhou S; Ke M; Yang H; Wang X
    J Immunol Res; 2022; 2022():2922832. PubMed ID: 35707002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
    Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D
    Front Immunol; 2023; 14():1181370. PubMed ID: 37600770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas.
    Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
    Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of metabolism-associated molecular patterns in prostate cancer.
    Yang B; Jiang Y; Yang J; Zhou W; Yang T; Zhang R; Xu J; Guo H
    BMC Urol; 2023 Jun; 23(1):104. PubMed ID: 37280589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients.
    Zhang R; Liu F
    J Transl Med; 2022 Oct; 20(1):453. PubMed ID: 36195908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma.
    Rao QW; Zhang SL; Guo MZ; Yuan FF; Sun JL; Qi F; Wang LS; Yang BW; Xia JL
    Cancer Med; 2020 Nov; 9(22):8318-8332. PubMed ID: 32955798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
    Liu L; Li Y; Tang S; Yang B; Zhang Q; Xiao R; Hou X; Liu C; Ma L
    Int J Biol Markers; 2023 Jun; 38(2):114-123. PubMed ID: 37192745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma.
    Hu QY; Liu J; Zhang XK; Yang WT; Tao YT; Chen C; Qian YH; Tang JS; Yao XS; Xu YH; Wang JH
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilizing Ubiquitination Patterns to Predict Prostate Cancer Prognosis and Devise a Therapeutic Response.
    Zhang X; Wang Y; Chang Y; Wang J; Yan S; Xiao Y; Guo T; Lou Y; Ma J; Xu W; Ren S
    Arch Esp Urol; 2023 May; 76(3):215-231. PubMed ID: 37340527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel five-gene immune-related risk model for the prognosis evaluation of prostate adenocarcinoma patients.
    Fei H; Chen X
    Am J Cancer Res; 2022; 12(5):2337-2349. PubMed ID: 35693084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A N
    Mei W; Jia X; Xin S; Liu X; Jin L; Sun X; Zhang JX; Zhang B; Yang G; Chen P; Ye L
    J Oncol; 2022; 2022():8604216. PubMed ID: 35602299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer.
    Zhai T; Dou M; Ma Y; Wang H; Liu F; Zhang L; Chong T; Wang Z; Xue L
    Lipids Health Dis; 2023 Mar; 22(1):39. PubMed ID: 36915125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and potential function of splicing events in prostate adenocarcinoma.
    Huang ZG; He RQ; Mo ZN
    Int J Oncol; 2018 Dec; 53(6):2473-2487. PubMed ID: 30221674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.
    Babasaki T; Sentani K; Sekino Y; Kobayashi G; Thang Pham Q; Katsuya N; Akabane S; Taniyama D; Hayashi T; Shiota M; Oue N; Teishima J; Matsubara A; Yasui W
    Cancer Med; 2021 Aug; 10(16):5574-5588. PubMed ID: 34240817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy.
    Wang X; Yu J; Yan J; Peng K; Zhou H
    BMC Urol; 2022 Mar; 22(1):37. PubMed ID: 35305591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.